CYPH Cypherpunk Technologies Inc. - Common Stock
$0.86
价格 · 八月 19, 2026
截至...的财报数据 八月 12, 2026
CYPH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.86
市值
$72M
P/E (TTM)
12.3
每股收益 (TTM)
$0.07
营收 (TTM)
—
股息收益率
—
ROE
6.1%
负债/权益
—
52周区间
$0 – $4
CYPH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
2020-12-31
→
2021-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
自由现金流
—
2017-12-31
→
2019-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CYPH
同行中位数
P/E (TTM)
12.3
—
P/S (TTM) (市销率 (TTM))
48.1
39.5
P/B (市净率)
0.5
1.6
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CYPH
同行中位数
ROA
4.5%
-45.3%
ROE
6.1%
-98.8%
ROIC
-12.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CYPH
同行中位数
Current Ratio (流动比率)
35.6
5.7
Quick Ratio (速动比率)
3.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CYPH
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CYPH
同行中位数
CYPH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-08-14
最低
$0.90
最高
$0.90
中位数目标
$0.90
+4.7%
平均目标
$0.90
+4.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2025年9月30日 | $-0.08 | $-0.24 | 0.16% |
| 2025年6月30日 | $-0.40 | $-0.30 | -0.10% |
| 2025年3月31日 | $-0.37 | $-0.39 | 0.02% |
| 2024年12月31日 | $-0.37 | $-0.37 | -0.00% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| ELTX | — | -3.1 | — | — | — | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| RNTX | — | -0.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| XBIT | — | -1.6 | — | — | — | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $2M | $2M | |
| R&D Expense | $26M | $57M | $73M | $45M | $32M | $20M | |
| SG&A Expense | $11M | $13M | $14M | $12M | $11M | $10M | |
| Operating Expenses | $41M | $70M | $87M | $57M | $43M | $30M | |
| Operating Income | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M | |
| Interest Expense | · | · | · | $54.0K | $41.0K | $39.0K | |
| Pretax Income | $10M | $-67M | $-81M | $-54M | $-41M | $-28M | |
| Income Tax | $5M | $585.0K | · | $147.0K | $-24.0K | $-2.0K | |
| Net Income | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| EPS (Basic) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| EPS (Diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| Shares (Basic) | 66,140,346 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| Shares (Diluted) | 70,672,358 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| EBITDA | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $47M | $71M | $66M | $115M | $52M | |
| Prepaid Expense | $40.0K | $86.0K | $183.0K | $351.0K | $769.0K | $130.0K | |
| Current Assets | $162M | $48M | $72M | $68M | $117M | $52M | |
| PP&E (Net) | · | $5.0K | $5.0K | $20.0K | $36.0K | $65.0K | |
| PP&E (Gross) | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | |
| Accum. Depreciation | $226.0K | $221.0K | $221.0K | $206.0K | $190.0K | $161.0K | |
| Other Non-current Assets | · | · | · | $30.0K | $90.0K | · | |
| Total Assets | $163M | $49M | $73M | $70M | $118M | $54M | |
| Accounts Payable | $2M | $5M | $6M | $6M | $4M | $3M | |
| Accrued Liabilities | $2M | $9M | $6M | $5M | $5M | $3M | |
| Current Liabilities | $5M | $14M | $13M | $11M | $10M | $7M | |
| Capital Leases | · | · | · | $262.0K | $37.0K | $144.0K | |
| Deferred Tax | $5M | · | · | · | · | · | |
| Total Liabilities | $10M | $14M | $13M | $11M | $10M | $8M | |
| Common Stock | $84.0K | $38.0K | $26.0K | $10.0K | $88.0K | $60.0K | |
| Paid-in Capital | $616M | $503M | $460M | $377M | $372M | $270M | |
| Retained Earnings | $-463M | $-467M | $-400M | $-318M | $-264M | $-223M | |
| AOCI | $-95.0K | $-120.0K | $106.0K | $128.0K | $-267.0K | $-579.0K | |
| Stockholders' Equity | $154M | $35M | $60M | $59M | $108M | $47M | |
| Liabilities + Equity | $163M | $49M | $73M | $70M | $118M | $54M | |
| Shares Outstanding | 83,851,051 | 38,329,894 | 25,565,414 | 9,902,137 | 59,657,742 | 59,657,742 |
现金流 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $5M | $4M | $3M | |
| Deferred Tax | $5M | · | · | $147.0K | $13.0K | $-42.0K | |
| Restructuring | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-44M | $-60M | $-44M | $-49M | $-35M | $-26M | |
| Investing Cash Flow | $-97M | · | $49M | · | · | $25.0K | |
| Financing Cash Flow | $108M | $37M | $-30.0K | $-210.0K | $98M | $74M | |
| Net Change in Cash | $-33M | $-23M | $5M | $-49M | $63M | $48M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2761.7% | -1902.6% | |
| Net Margin | · | · | · | · | -2705.8% | -1834.3% | |
| Pretax Margin | · | · | · | · | -2707.4% | -1834.4% | |
| EBITDA Margin | · | · | · | · | -2761.7% | -1902.6% | |
| ROA | 4.5% | -110.8% | -113.7% | -58.0% | -47.1% | -89.0% | |
| ROE | 6.1% | -160.8% | -123.2% | -84.7% | -36.1% | -55.1% | |
| ROIC | -12.8% | -201.6% | · | -96.7% | -38.4% | -61.2% |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 | 7.1 | |
| Quick Ratio | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 | 7.1 | |
| Interest Coverage | · | · | · | -1051.2 | -1010.4 | -731.8 |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 0.00% | · |
估值 (TTM) 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | |
| Net Income TTM | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| Market Cap | $97M | $110M | $106M | $397M | $2.86B | $1.34B | |
| P/E | 16.6 | -1.6 | -1.0 | -0.9 | -68.9 | -35.7 | |
| P/S | 64.8 | 73.5 | 70.6 | 265.0 | 1907.7 | 894.9 | |
| P/B | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Tangible Book | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Cash Flow | -2.2 | -1.8 | -2.4 | -8.1 | -81.4 | -51.7 | |
| Earnings Yield | 6.0% | -63.0% | -96.0% | -107.1% | -1.5% | -2.8% |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $197.0K | $161.0K | $975.0K | $1M | $11M | $13M | $13M | $15M | $18M | $11M | $12M | $12M | $11M | $39M | $11M | $12M | |
| SG&A Expense | $4M | $5M | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $3M | $17M | $16M | $16M | $18M | $21M | $15M | $15M | $15M | $15M | $43M | $14M | $15M | |
| Operating Income | $-5M | $-5M | $-5M | $-3M | $-17M | $-16M | $-16M | $-18M | $-21M | $-15M | $-15M | $-15M | $-15M | $-43M | $-14M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5.0K | $11.0K | |
| Pretax Income | $41M | $-82M | $45M | $-3M | $-17M | $-15M | $-16M | $-17M | · | · | $-12M | $-14M | · | · | · | · | |
| Income Tax | $2M | $-5M | $5M | $202.0K | · | · | $-123.0K | $708.0K | · | · | · | · | · | · | · | · | |
| Net Income | $39M | $-77M | $40M | $-3M | $-17M | $-15M | $-15M | $-18M | $-20M | $-14M | $-12M | $-14M | $-13M | $-42M | $-12M | $-15M | |
| EPS (Basic) | $0.21 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| EPS (Diluted) | $0.18 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| Shares (Basic) | 184,328,441 | 168,103,535 | -58,018,506 | 41,444,979 | 41,444,979 | 41,268,894 | -69,795,724 | 41,209,639 | 39,122,662 | 27,014,100 | -34,186,875 | 26,987,182 | 14,710,375 | 12,934,427 | -124,573,830 | 11,323,909 | |
| Shares (Diluted) | 217,343,013 | 168,103,535 | -53,486,494 | 41,444,979 | 41,444,979 | 41,268,894 | -69,795,724 | 41,209,639 | 39,122,662 | 27,014,100 | -34,186,875 | 26,987,182 | 14,710,375 | 12,934,427 | -124,573,830 | 11,323,909 | |
| EBITDA | $-5M | $-5M | · | $-3M | $-17M | $-16M | · | $-18M | $-21M | $-15M | · | $-15M | $-15M | $-43M | · | $-15M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $7M | $14M | $10M | $18M | $33M | $47M | $63M | $78M | $55M | $71M | $81M | $91M | $102M | $66M | $78M | |
| Prepaid Expense | $539.0K | $768.0K | $40.0K | $69.0K | $292.0K | $446.0K | $86.0K | $209.0K | $354.0K | $526.0K | $183.0K | $265.0K | $419.0K | $590.0K | $351.0K | $374.0K | |
| Current Assets | $138M | $82M | $162M | $10M | $19M | $34M | $48M | $64M | $80M | $56M | $72M | $82M | $94M | $105M | $68M | $80M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | · | · | · | $5.0K | $9.0K | $13.0K | $16.0K | $20.0K | $24.0K | |
| PP&E (Gross) | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | |
| Accum. Depreciation | · | · | $226.0K | · | · | · | $221.0K | · | · | · | $221.0K | · | · | · | $206.0K | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $15.0K | $30.0K | $45.0K | |
| Total Assets | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Accounts Payable | $588.0K | $516.0K | $2M | $4M | $7M | $6M | $5M | $6M | $8M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | |
| Accrued Liabilities | $1M | $2M | $2M | $4M | $7M | $7M | $9M | $9M | $7M | $4M | $6M | $5M | $5M | $4M | $5M | $5M | |
| Current Liabilities | $2M | $3M | $5M | $9M | $14M | $14M | $14M | $16M | $16M | $10M | $13M | $11M | $12M | $10M | $11M | $12M | |
| Capital Leases | · | · | · | · | · | · | · | · | $39.0K | $154.0K | · | · | $38.0K | $152.0K | $262.0K | $369.0K | |
| Deferred Tax | $2M | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4M | $3M | $10M | $9M | · | · | $14M | $16M | $16M | $11M | · | $11M | $12M | $11M | $11M | $12M | |
| Common Stock | $108.0K | $94.0K | $84.0K | $41.0K | $41.0K | $41.0K | $38.0K | $38.0K | $38.0K | $26.0K | $26.0K | $26.0K | $26.0K | $119.0K | $10.0K | $99.0K | |
| Paid-in Capital | $640M | $624M | $616M | $506M | $505M | $504M | $503M | $501M | $500M | $461M | $460M | $458M | $457M | $388M | $377M | $375M | |
| Retained Earnings | $-500M | $-540M | $-463M | $-503M | $-499M | $-483M | $-467M | $-452M | $-434M | $-413M | $-400M | $-387M | $-373M | $-360M | $-318M | $-306M | |
| AOCI | $-81.0K | $-86.0K | $-95.0K | $-104.0K | $-82.0K | $-113.0K | $-120.0K | $6.0K | $3.0K | $-120.0K | $106.0K | $760.0K | $414.0K | $355.0K | $128.0K | $690.0K | |
| Stockholders' Equity | $139M | $84M | $154M | $3M | $6M | $21M | $35M | $49M | $66M | $47M | $60M | $72M | $84M | $28M | $59M | $70M | |
| Liabilities + Equity | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Shares Outstanding | 107,764,382 | 93,927,528 | 83,851,051 | 41,439,529 | 41,439,529 | 41,439,529 | 38,329,894 | 38,264,464 | 38,264,464 | 25,603,417 | 25,565,414 | 25,565,414 | 25,565,414 | 119,410,992 | 9,902,137 | 99,021,376 |
现金流 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $303.0K | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | $2M | $-5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $0 | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-7M | $-8M | $-14M | $-14M | $-16M | $-16M | $-14M | $-16M | $-10M | $-10M | $-10M | $-13M | $-13M | $-12M | |
| Investing Cash Flow | $-10M | $-9M | · | · | · | · | · | · | · | · | $0 | $0 | $-348.0K | $49M | · | · | |
| Financing Cash Flow | $13M | $5M | $108M | $-121.0K | $-119.0K | $-61.0K | $104.0K | $-66.0K | $37M | $29.0K | $0 | $-1.0K | $0 | $-29.0K | $0 | $0 | |
| Net Change in Cash | $935.0K | $-7M | $4M | $-8M | $-15M | $-15M | $-16M | $-16M | $24M | $-16M | $-10M | $-11M | $-11M | $37M | $-13M | $-13M |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 48.3% | -126.2% | · | -8.6% | -32.8% | -33.2% | · | -24.6% | -22.7% | -16.8% | · | -16.6% | -14.1% | -39.4% | · | -14.4% | |
| ROE | 54.3% | -146.7% | · | -12.8% | -46.6% | -45.3% | · | -30.0% | -26.9% | -36.5% | · | -19.3% | -16.0% | -66.0% | · | -16.2% | |
| ROIC | -3.2% | -5.3% | · | -125.1% | · | · | · | -38.0% | · | · | · | · | · | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 79.2 | 27.3 | · | 1.2 | 1.3 | 2.4 | · | 4.0 | 5.1 | 5.4 | · | 7.4 | 8.0 | 10.2 | · | 6.8 | |
| Quick Ratio | 4.4 | 2.2 | · | 1.1 | 1.3 | 2.3 | · | 3.9 | 5.0 | 5.3 | · | 7.3 | 7.8 | 9.9 | · | 6.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1389.8 |
估值 (TTM) 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-58M | $-113M | · | $-54M | $-70M | $-68M | · | $-66M | $-61M | $-83M | · | $-84M | $-87M | $-84M | · | $-54M | |
| Market Cap | $66M | $75M | · | $19M | $12M | $13M | · | $98M | $75M | $68M | · | $35M | $80M | $406M | · | $871M | |
| P/E | -0.8 | -0.6 | · | -0.4 | -0.2 | -0.2 | · | -1.3 | -0.8 | -0.5 | · | -0.2 | -0.4 | -0.6 | · | -2.9 | |
| P/S | 44.0 | 49.8 | · | 12.5 | 8.2 | 8.4 | · | 65.6 | 50.0 | 45.4 | · | 23.5 | 53.3 | 270.7 | · | 580.9 | |
| P/B | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Tangible Book | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Cash Flow | · | -21.8 | · | · | · | -0.9 | · | · | · | -4.4 | · | · | · | -32.0 | · | · | |
| Earnings Yield | -124.2% | -164.8% | · | -284.1% | -582.5% | -603.3% | · | -77.0% | -125.0% | -194.4% | · | -434.1% | -223.0% | -181.2% | · | -34.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | — | — | — | — | $2M |
| 营业利润率 % | — | — | — | — | -2761.7% |
| 净收入 | $5M | $-68M | $-81M | $-55M | $-41M |
| 稀释后每股收益 (EPS) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 |
| 速动比率 | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 57 家申报者 · $11.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 16 (+4 与上一季度对比) | 5 (-3 与上一季度对比) | 18 (+11 与上一季度对比) | 7 (-3 与上一季度对比) | +8.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 21 位内幕人士 · 7 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | 2026年7月1日 A | 106858 | 0 | 2 | $-2123642 |
| Augustine Lawlor | Chief Operating Officer | 2025年3月28日 M | 19789 | 0 | 0 | $0 |
| William Patrick Mcevoy III | Chief Investment Officer | 2026年7月1日 A | — | 0 | 0 | $0 |
| Jason Baum | Chief Scientific Officer | 2025年3月28日 M | 15896 | 0 | 0 | $0 |
| Christine Granfield | VP, Head of Reg Affairs/Qual | 2025年3月28日 M | 15896 | 0 | 0 | $0 |
| John Mark O'Mahony | Chief Manufacturing Officer | 2025年3月28日 M | 27500 | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | 2025年3月28日 M | 27500 | 0 | 0 | $0 |
| Khing Djien Oei | 董事 | 2026年7月1日 A | 168750 | 0 | 0 | $0 |
| Patricia A. Martin | 董事 | 2026年7月1日 A | 168750 | 0 | 0 | $0 |
| Christian M Richard | 董事 | 2026年7月1日 A | 168750 | 0 | 0 | $0 |
| Thomas John Dietz | 董事 | 2026年7月1日 A | 152500 | 0 | 0 | $0 |
| Nissim Mashiach | 董事 | 2026年7月1日 A | 168750 | 0 | 0 | $0 |
| William Li | 董事 | 2026年7月1日 A | 168750 | 0 | 0 | $0 |
| Christopher Mirabelli | 董事 | 2026年3月26日 S | 130376 | 0 | 3 | $-2166242 |
| Richard Schilsky | 董事 | 2026年3月13日 M | 168750 | 0 | 0 | $0 |
| Joseph Loscalzo | 董事 | 2026年3月13日 M | 168750 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | 董事 | 2026年3月13日 M | 168963 | 0 | 1 | $-822178 |
| John W Littlechild | 董事 | 2020年3月2日 A | — | 0 | 0 | $0 |
| Harold R Werner | 10% 所有者 | 2018年7月30日 J | — | 0 | 0 | $0 |
| Eli Lilly and Company | 10% 所有者 | 2018年7月30日 A | — | 0 | 0 | $0 |
| Monica Bertagnolli | — | 2022年1月31日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Winklevoss Capital Fund, LLC, Winklevoss Treasury Investments, LLC, Winklevoss Capital Management, LLC, Tyler Howard Winklevoss, Cameron Howard Winklevoss ×2 申报 | 2025年11月21日 | 19.90% | 修订 | — | SEC |
| BeiGene, Ltd. ×4 申报 | 2024年10月31日 | 0.00% | 修订 | — | SEC |
| Valence Helix Investments III, LLC, Valence Helix Investments, LLC, Eric Roberts, Graham Crooke, Rachel Leheny, Philip Sawyer, Evgeny Zaytsev ×2 申报 | 2020年1月21日 | — | 初始申报 | — | SEC |
| HealthCare Ventures IX, L.P., HealthCare Partners IX, L.P., HealthCare Partners IX, LLC, HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, HealthCare Ventures Strategic Fund, L.P., HealthCare Strategic Partners, LLC, Christopher Mirabelli, Augustine Lawlor, Douglas E. Onsi, James H. Cavanaugh, John W. Littlechild, Harold Werner ×4 申报 | 2019年2月8日 | — | 初始申报 | 资本结构 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 2 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。